<DOC>
	<DOCNO>NCT00153062</DOCNO>
	<brief_summary>The purpose trial determine extended-release dipyridamole + aspirin [ Aggrenox , Asasa ntin ] superior clopidogrel [ Plavix ] , telmisartan [ Micardis , Gliosartan , Kinzal , Kinzalm ono , Predxal , Pritor , Samertan , Telmisartan ] superior placebo , presence background antihypertensive therapy , prevention second stroke patient recently suffer stroke therefore high risk suffer another one .</brief_summary>
	<brief_title>PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Inclusion criterion : Male female subject 55 year older suffer ischemic stroke within past 90 day meet inclusion criterion . Include also patient age 50 54 year and/or 90 120 day qualify stroke provide patient least two follow additional risk factor : Diabetes mellitus Hypertension ( systolic BP ¿ 140 diastolic BP ¿ 90 ) Smoker time qualify stroke Obesity ( BMI &gt; 30 ; BMI=weight ( kg ) / [ height ( ) ] 2 ) Previous vascular disease ( stroke , MI , peripheral arterial disease prior qualify stroke ) Endorgandamage ( retinopathy , LVH , microalbuminuria ) Hyperlipidemia Exclusion criterion : hemorrhagic stroke ( must rule imaging ) ; unable give inform consent ; know brain tumor , severe renal hepatic insufficiency , current active peptic ulcer disease , severe coronary artery disease include unstable angina pectoris MI within previous 3 month , history hemostatic disorder systemic bleeding ; hyperkalemia ; uncorrected volume sodium depletion ; prestroke history dementia ; modify Rankin score great 4 ; qualify stroke induce surgical cardiovascular procedure ; uncontrolled hypertension entry 180/110 mmHg ( goal BPs low ) ; SBP 120 mmHg less hospitalized patient ; currently take ARB able willing switch alternative ; require plan continue treatment antithrombotics anticoagulant include heparin warfarin nonstudy platelet inhibitor ; syndrome asthma , rhinitis nasal polyp ; schedule major surgery , carotid endarterectomy , carotid angioplasty ( 4 week post surgery allow ) ; unlikely release hospital follow qualify stroke presence severe disability likely lead bedridden demented nonvascular disease condition make unlikely patient survive end trial ; history thrombocytopenia neutropenia .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>